| Literature DB >> 31387884 |
Peter A Kavsak1, Carolyn S P Lam2, Amy K Saenger3,4, Allan S Jaffe5,6, Paul Collinson7, Kari Pulkki8, Tobjørn Omland9,10, Guillaume Lefèvre11, Richard Body12,13,14, Jordi Ordonez-Llanos15,16, Fred S Apple17,4.
Abstract
The IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has directives and initiatives focused on providing evidence-based educational resources to aid and improve understanding around key analytical and clinical aspects of cardiac biomarkers used in clinical practice and the research setting. As a task force, we have previously published position statements and recommendations focused on use and analytical aspects of high-sensitivity cardiac troponin assays. The current educational document is the first from the C-CB highlighting important biochemical, analytical, and clinical aspects as they relate to the natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), with a focus on heart failure.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31387884 DOI: 10.1373/clinchem.2019.306621
Source DB: PubMed Journal: Clin Chem ISSN: 0009-9147 Impact factor: 8.327